Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD)

[Image: see text] Psilocybin, a serotonergic agonist, was granted a “breakthrough therapy” status by the Food and Drug Administration for clinical trials involving major depressive disorder and treatment-resistant depression. The direct phosphorylation of psilocin to psilocybin that uses a fast crys...

Descripción completa

Detalles Bibliográficos
Autores principales: Kargbo, Robert B., Sherwood, Alexander M., Meisenheimer, Poncho, Lenoch, Kelsey, Abebe, Solomon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851641/
https://www.ncbi.nlm.nih.gov/pubmed/35187358
http://dx.doi.org/10.1021/acsomega.1c06708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851641/
https://www.ncbi.nlm.nih.gov/pubmed/35187358
http://dx.doi.org/10.1021/acsomega.1c06708

Ejemplares similares